"/> Novus Biologicals™ Peptide bloquant d’anticorps BC… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps BCL2L10

Réf. : BL-RE-046400Réf. fabricant : 18249495 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
10017
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77224. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 16 amino acids near the center of human LSD1.

Points forts

Source

Synthetic

(Accession #: NP_065129) The BCL2L10 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-046400
Réf. fabricant18249495
Gene ID (Entrez)10017
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77224. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneApoptosis regulator Bcl-B, apoptotic protein NrH, bcl2-L-10, BCL2-like 10 (apoptosis facilitator), bcl-2-like protein 10, BCLB, BCL-B, Boo, Diva, MGC129810, MGC129811
Symbole de gène(s)BCL2L10
Type de produitBCL2L10
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne16 amino acids near the center of human LSD1
Une question, une configuration particulière ?
Contactez-nous pour un devis.